https://www.selleckchem.com/pr....oducts/ccg-203971.ht
Clinical success of RET using platelet-rich plasma (PRP), blood clot (BC), and platelet-rich fibrin (PRF) scaffolds ranged between 91.66%-100%, 84.61%-100%, and 77%-100% respectively. The different scaffolds did not show any statistically significant difference in clinical success (PRF vs BC [P=1.000], PRP vs BC [P=1.000], and PRF vs PRP [P=.999]), apical root closure (PRF vs BC [P=1.000], PRP vs BC [P=.835], PRF vs PRP [P=.956]), and pulp sensibility (PRF vs BC [P=.980], PRP versus BC [P=.520], and PRF vs PRP [P=.990]). The intracan
Maject53
GO HERE —————->> www.get.salary7.com
Удалить комментарий
Вы уверены, что хотите удалить этот комментарий?